logo

Blogs Forms State Regulations Client Login
  • About E&I
    • Company Profile
    • Scope of Studies
    • Our Board
    • Contact Us
    • Services
      • Fees
      • Translation Services
      • Contracting with Us
    • Our Compliance Policy
    • Electronic Access / Server
  • Investigators / Sites
    • About Investigator Section
    • Initial Submissions
      • Joining a Multi-site Study
      • Submitting Single-site Studies
      • Submitting Investigator Initiated Studies
      • Other Review Categories
      • Individual/Emergency/HUD
      • Biological Specimens
    • Post Approval Reporting Obligations
      • Modifications/Changes in Research
      • Reporting Violations/Problems
      • New Information
    • Continuing Review
    • Recruitment / Advertising
    • Closing a Study
    • Investigator Training
  • Sponsor / CRO
    • About Sponsor Section
    • Initial Sponsor Submission
      • Multi-site Studies
    • Protocol Amendments and Revisions
    • Reporting Obligations/Agreements
      • Unanticipated Problems
      • New Information
    • Continuing Review
    • Closing a Study
    • Extra
  • Research Participants
    • About Participant Section
    • Frequently Asked Questions
    • Links
  • Forms
  • Search
Home FDA News FDA News

Guidance

  • IRB Review
    • Is IRB Review Required?
    • Types of Review Available
    • IRB Review Exemption
    • More on Expedited Review
    • Protocol Design Issues
    • Non-Local Issues
    • Risk Analysis
    • Multi-center Studies
  • Subject Protection
    • Defining an HRPP
    • E&I's HRPP
    • E&I's Conflict of Interest Policy
    • E&I's Compliance Policy / Registration
    • E&I's PI / Site Training Requirements
    • Basics of HRPP Development
  • Program & Responsibility
    • FWA Basics
    • FWA Policy Overview
    • FWA Sample SOP
  • Informed Consent (IC)
    • IC Overview
    • IC Process
    • E&I's HIPAA Policy
  • Biological Specimens
    • Points to Consider
    • Consent Template
  • Device Studies
    • Device Basics
    • NSR vs SR
    • E&I NSR Policy
    • Risk Evaluation Tool
  • Humanitarian Devices
    • Humanitarian Devices Basics
    • HUD Part 812.100
  • Non-Invasive Research
    • Clinical Effectiveness Research (CER)
    • Outcomes Research
    • Qualitative Research

Regulatory Guidance

  • FDA Guidance
  • OHRP Guidance
  • Belmont Report
  • State Regulations

Resources

  • FDA News
  • Industry News
  • Pharmaceuticals News
FDA News
Food and Drug Adminstration (FDA): CDRHNew
CDRH Logo
  • Class I Medical Device Recall: Cook Medical, Inc., Zilver PTX Drug-Eluting Peripheral Stent
  • PMA Final Decisions for March 2013
  • Consumer Information on: SEDASYS® Computer-Assisted Personalized Sedation System - P080009
  • Meeting Announcement: June 26, 2013 General and Plastic Surgery Devices Panel of the Medical Devices Meeting Announcement
  • Consumer Information on: Selenia Dimensions 3D System - P080003S001
Ethical and Independent Review Services © 2010